Locations:

Image of Note: Using Robotics to Expand Esophagectomy Options

A snapshot of evolving practice

Image of Note: Using Robotics to Expand Esophagectomy Options

As one of a limited number of cardiothoracic surgery programs that offer esophageal procedures, Cleveland Clinic’s Department of Thoracic and Cardiovascular Surgery has seen its esophageal surgery volumes rise in recent years, surging to 261 cases in 2016.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Esophagectomy for esophageal cancer is one procedure where volume-based expertise is yielding the greatest outcome dividends: Across 153 esophagectomies from July 2013 through June 2016, Cleveland Clinic surgeons achieved among the lowest risk-adjusted combined morbidity and 30-day mortality rates in the entire country, with a standardized incidence ratio of 0.55 (95% CI, 0.38-0.75), according to the Society of Thoracic Surgeons General Thoracic Surgery Database.

Now Cleveland Clinic surgeons are increasingly turning to robotics to offer a minimally invasive option to patients requiring esophagectomy. A snapshot of robotic esophagectomy is presented above, showing engagement of an end-to-end anastomosis stapler to connect the gastric conduit with the proximal esophagus.

“Minimally invasive esophagectomy is a complex operation and requires a multidisciplinary approach and very careful patient selection,” says Sudish Murthy, MD, PhD, Section Head of Thoracic Surgery.

“The best way to achieve excellent results after esophagectomy is to tailor the operation for the patient and his or her cancer,” adds Siva Raja, MD, PhD, Surgical Director, Center for Esophageal Disorders. “We are facile in performing all the variations of esophagectomy, even in the setting of chemotherapy and radiation, to help our patients achieve their cure.”

Advertisement

Related Articles

physician pointing to a heart model and speaking to a woman

Cardiovascular Implications of Clonal Hematopoiesis of Indeterminate Potential (CHIP)

They generally depend on the mutated gene, clone size and clinical setting

cardiac echo and cardiac CT images side by side

Indexed CTA Measures Sharpen Risk Prediction in Ascending Aortopathy

Large analysis adds to evidence that absolute diameter alone may miss vulnerable patients

operating room during robotic lung transplant surgery

Successful First Case Launches Cleveland Clinic’s Robotic Lung Transplant Program

Procedure places the center among only a handful worldwide to offer the minimally invasive approach

stylized illustration of cholesterol particle floating in bloodstream

Novel siRNA Produces Deep, Durable Reduction in Lp(a)

Phase 1 trial shows up to 97% decrease through 48 weeks with good tolerability

converging lines on a graph pointing downward

Oxidized Phospholipids Track Closely With Lp(a) Reductions in Clinical Trial

Post hoc ALPACA analysis boosts biological rationale for ongoing outcomes trial of lepodisiran

sight picture overlaid on DNA double helix

Positive Effects of CRISPR-Cas9 Gene Editing for Dyslipidemia Endure Through 1 Year

Durability findings propel potential one-time treatment approach to phase 1b testing

Doctor examining patient's heart with a stethoscope

New Guideline Calls on Cardiologists to Think Beyond Silos When Managing CKM Syndrome

Practical takeaways for the reality of overlapping cardiovascular, kidney and metabolic disease

illustration showing device inserted into heart chambers via blood vessels

IMPACT Trial Supports Safety, Feasibility of Preemptive LV Unloading in High-Risk Cardiac Surgery

First prospective study shows early extubation and low vasoactive/inotropic medication use

Ad